T0	Chemical 152 159	sulfide
T10	Chemical 511 514	H₂S
T11	Gene-Protein 577 580	CBS
#4	AnnotatorNotes T11	HGNC:1550
T12	Disease 614 630	vascular disease
#5	AnnotatorNotes T12	DOID:178
T13	Chemical 699 702	H₂S
T15	Chemical 788 791	H₂S
T16	Gene-Protein 831 834	CTH
T18	Disease 927 943	vascular disease
T19	Disease 957 991	Deficiency in bioavailable sulfide
#11	AnnotatorNotes T19	not found
T20	Chemical 984 991	sulfide
T23	Chemical 1120 1132	homocysteine
T25	Disease 1217 1220	CVD
T26	Chemical 1306 1313	sulfide
T27	Disease 1377 1401	chronic vascular disease
#17	AnnotatorNotes T27	DOID:178
T29	Chemical 1595 1617	pyridoxal-5’-phosphate
T3	Disease 194 197	CVD
T5	Chemical 258 265	sulfide
T6	Disease 287 290	CVD
T7	Chemical 372 379	sulfide
T1	Chemical 161 164	ALS
T2	Chemical 170 173	BSS
T4	Biomarker 238 272	reduction in plasma sulfide levels
R1	Association Arg1:T4 Arg2:T6	
T8	Chemical 381 384	ALS
T9	Biomarker 547 567	polymorphisms in CTH
R2	Risk-Factor Arg1:T9 Arg2:T12	
T14	Gene-Protein 661 664	CTH
T21	Chemical 390 393	BSS
T22	Gene-Protein 564 567	CTH
#1	AnnotatorNotes T22	HGNC:2501
T17	Gene-Protein 1252 1255	CTH
T24	Gene-Protein 1091 1094	CTH
T30	Gene-Protein 1039 1042	CTH
T31	Gene-Protein 1591 1594	CTH
T32	Gene-Protein 1170 1173	CTH
T28	Biomarker 1015 1042	polymorphic variants of CTH
R3	Association Arg1:T28 Arg2:T19	
#2	AnnotatorNotes T3	DOID:178
T33	Gene-Protein 836 839	CSE
T34	Biomarker 777 827	endogenous H₂S production is significantly reduced
R4	Association Arg1:T34 Arg2:T18	
T35	Variant 1174 1182	1364 G-T
T36	Variant 1260 1276	403Ser to 403Ile
R5	Variant-Of Arg1:T32 Arg2:T35	
R6	Variant-Of Arg1:T17 Arg2:T36	
R7	Association Arg1:T36 Arg2:T27	
T37	Variant 1095 1098	SNP
R8	Variant-Of Arg1:T24 Arg2:T37	
#3	AnnotatorNotes T36	p.Ser403Ile
T38	Biomarker 146 159	total sulfide
T39	Biomarker 161 164	ALS
T40	Biomarker 170 173	BSS
